{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:51:12Z","timestamp":1790700672208,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.nbd.2011.12.040","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T16:31:53Z","timestamp":1325694713000},"page":"597-606","source":"Crossref","is-referenced-by-count":146,"title":["Animal models of the non-motor features of Parkinson's disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Kimberly","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Chesselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.12.040_bb0005","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.040_bb0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/mds.21560","article-title":"Bowel movement frequency in late-life and incidental Lewy bodies","volume":"22","author":"Abbott","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0015","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s007020050228","article-title":"Nocturnal sleep structure and temperature slope in MPTP treated monkeys","volume":"106","author":"Almirall","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.040_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2008.05.017","article-title":"Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease","volume":"31","author":"Ardayfio","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0030","first-page":"116","article-title":"Association between sporadic Parkinson disease and interleukin-1 beta-511 gene polymorphisms in the Turkish population","volume":"21","author":"Arman","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.nbd.2011.12.040_bb0035","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.expneurol.2009.07.019","article-title":"Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model","volume":"219","author":"Barraud","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000316613","article-title":"Nonmotor disturbances in Parkinson's disease","volume":"8","author":"Bassetti","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2010.11.023","article-title":"Modeling Parkinson's disease genetics: altered function of the dopamine system in Adh4 knockout mice","volume":"217","author":"Belin","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neurobiolaging.2008.03.008","article-title":"PITX3 polymorphism is associated with early onset Parkinson's disease","volume":"31","author":"Bergman","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.expneurol.2004.11.013","article-title":"Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates","volume":"192","author":"Bibbiani","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0065","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease","volume":"130","author":"Boeve","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.040_bb0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.040_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.040_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1476-5381.1971.tb07089.x","article-title":"Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine","volume":"42","author":"Breese","year":"1971","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneurol.2010.260","article-title":"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues","volume":"68","author":"Bronstein","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","article-title":"Pesticides and Parkinson's disease\u2014is there a link?","volume":"114","author":"Brown","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.nbd.2011.12.040_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0105","first-page":"11","article-title":"Biochemical and pharmacological aspects of parkinsonism","volume":"51","author":"Carlsson","year":"1972","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.nbd.2011.12.040_bb0110","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.040_bb0115","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nbd.2007.11.011","article-title":"Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function","volume":"29","author":"Chandran","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0125","series-title":"Parkinson's Disease: The Non-Motor Issues","author":"Chaudhuri","year":"2011"},{"key":"10.1016\/j.nbd.2011.12.040_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2982.2008.01226.x","article-title":"Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism","volume":"21","author":"Chaumette","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.nbd.2011.12.040_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0166-2236(96)10052-7","article-title":"Basal ganglia and movement disorders: an update","volume":"19","author":"Chesselet","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.03.053","article-title":"Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine","volume":"1213","author":"Chudler","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0145","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2011.12.040_bb0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.npp.1301153","article-title":"L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease","volume":"32","author":"Cools","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2011.12.040_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0160","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1460-9568.2004.03586.x","article-title":"Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates","volume":"20","author":"Decamp","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainres.2009.01.028","article-title":"Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model","volume":"1262","author":"Decamp","year":"2009","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2011.12.040_bb0170","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1002\/mds.22637","article-title":"Evidence in favor of Braak staging of Parkinson's disease","volume":"25","author":"Dickson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0175","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1212\/01.WNL.0000130455.38550.9D","article-title":"Quantitative measurement of pain sensation in patients with Parkinson disease","volume":"62","author":"Djaldetti","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.040_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0006-8993(92)91385-R","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice","volume":"586","author":"Dluzen","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.040_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.410320116","article-title":"Lack of major olfactory dysfunction in MPTP-induced parkinsonism","volume":"32","author":"Doty","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870060211","article-title":"Gastrointestinal symptoms in Parkinson's disease","volume":"6","author":"Edwards","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nurt.2007.12.001","article-title":"Current status of symptomatic medical therapy in Parkinson's disease","volume":"5","author":"Factor","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2011.12.040_bb0210","first-page":"751","article-title":"Parkinsonism","author":"Fahn","year":"2010"},{"key":"10.1016\/j.nbd.2011.12.040_bb0215","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(69)90081-8","article-title":"Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra","volume":"23","author":"Faull","year":"1969","journal-title":"Exp. Neurol."},{"issue":"Pt. 5","key":"10.1016\/j.nbd.2011.12.040_bb0220","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.040_bb0225","first-page":"3","article-title":"Experimental models of Parkinson's disease","volume":"60","author":"Feger","year":"2002","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.nbd.2011.12.040_bb0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2011.12.040_bb0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00001756-199512290-00024","article-title":"Long-term cognitive impairment in MPTP-treated rhesus monkeys","volume":"7","author":"Fernandez-Ruiz","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.12.040_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(97)00008-5","article-title":"Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra","volume":"753","author":"Ferrante","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2011.12.040_bb0250","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0260","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.neuroscience.2006.07.005","article-title":"Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein","volume":"142","author":"Fleming","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.040_bb0265","first-page":"N3","article-title":"Impaired reversal learning in transgenic mice overexpressing human wildtype alpha-synuclein","volume":"341.1","author":"Fleming","year":"2008","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.nbd.2011.12.040_bb0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory deficits in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"Fleming","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0275","first-page":"K8","article-title":"Alterations in heart rate variability in transgenic mice overexpressing human wildtype alpha synuclein","volume":"531.9","author":"Fleming","year":"2009","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.nbd.2011.12.040_bb0280","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0285","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2007.08.014","article-title":"The transcription factor PITX3 is associated with sporadic Parkinson's disease","volume":"30","author":"Fuchs","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0290","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","article-title":"Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour","volume":"210","author":"George","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0295","series-title":"Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics","author":"Gerlach","year":"2011"},{"key":"10.1016\/j.nbd.2011.12.040_bb0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0361-9230(01)00501-9","article-title":"Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats","volume":"55","author":"Gevaerd","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2011.12.040_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/hmg\/ddi445","article-title":"Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women","volume":"15","author":"Glatt","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.040_bb0310","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.040_bb0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.040_bb0320","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1124\/jpet.103.051714","article-title":"Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease","volume":"306","author":"Goldstein","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2011.12.040_bb0325","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson's disease","volume":"12","author":"Gonera","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0895","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12031-011-9520-8","article-title":"Global Depletion of Dopamine Using Intracerebroventricular 6-Hydroxydopamine Injection Disrupts Normal Circadian Wheel-Running Patterns and PERIOD2 Expression in the Rat Forebrain","volume":"45 (2)","author":"Gravotta","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0335","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12035-009-8059-y","article-title":"Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons","volume":"39","author":"Guillot","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0345","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","article-title":"The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism","volume":"17","author":"Ha","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0350","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0355","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mds.23669","article-title":"Milestones in Parkinson's disease\u2014clinical and pathologic features","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0360","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.040_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0375","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0380","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0385","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2011.12.040_bb0390","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","article-title":"Formation and development of Lewy pathology: a critical update","volume":"256","author":"Jellinger","year":"2009","journal-title":"J. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2011.12.040_bb0395","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2011.12.040_bb0400","first-page":"S16","article-title":"Functional models of Parkinson's disease: a valuable tool in the development of novel therapies","volume":"64","author":"Jenner","year":"2008","journal-title":"Ann. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2011.12.040_bb0405","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","article-title":"From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(99)00068-6","article-title":"Akinesia and postural abnormality after unilateral dopamine depletion","volume":"104","author":"Johnson","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0415","first-page":"143547","article-title":"Neurobiology of depression and anxiety in Parkinson's disease","volume":"2011","author":"Kano","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0420","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11064-011-0469-3","article-title":"Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease","volume":"36","author":"Kaur","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0425","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0430","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.040_bb0435","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","article-title":"Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model","volume":"25","author":"Kingsbury","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.040_bb0445","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2011.08.003","article-title":"Circadian dysfunction in a mouse model of Parkinson's disease","volume":"232","author":"Kudo","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0450","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002512-200016050-00006","article-title":"Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease","volume":"16","author":"Kulisevsky","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0455","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","article-title":"Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes","volume":"19","author":"Kuo","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.040_bb0460","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00221-008-1268-1","article-title":"MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations","volume":"186","author":"Laloux","year":"2008","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0465","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0470","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2010.05.008","article-title":"The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons","volume":"40","author":"Lawal","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0480","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.neurobiolaging.2009.03.015","article-title":"Transcription factor PITX3 gene in Parkinson's disease","volume":"32","author":"Le","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0485","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archneurol.2008.561","article-title":"Overview of the extranigral aspects of Parkinson disease","volume":"66","author":"Lim","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0490","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1523\/JNEUROSCI.0618-11.2011","article-title":"Alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies","volume":"31","author":"Lim","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0495","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1371\/journal.pone.0000513","article-title":"The role of the substantia nigra pars compacta in regulating sleep patterns in rats","volume":"2","author":"Lima","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.12.040_bb0500","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0505","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2011.12.040_bb0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","article-title":"Genetic mouse models of Parkinson's disease: the state of the art","volume":"184","author":"Magen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0515","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.040_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2011.05.006","article-title":"The importance of non-motor disturbances to quality of life in Parkinson's disease","author":"Martinez-Martin","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0525","doi-asserted-by":"crossref","first-page":"e19338","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.12.040_bb0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0535","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.expneurol.2010.08.005","article-title":"Sleep alterations in an environmental neurotoxin-induced model of parkinsonism","volume":"226","author":"McDowell","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0540","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nbd.2011.12.040_bb0545","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/exnr.1998.7008","article-title":"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease","volume":"156","author":"Miller","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0550","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/j.1460-9568.2004.03694.x","article-title":"Vigilance states in a parkinsonian model, the MPTP mouse","volume":"20","author":"Monaca","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0555","first-page":"U28","article-title":"Mice overexpressing human wildtype alpha-synuclein under the Thy-1 promoter exhibit anomalies in behavioral tests of anxiety","volume":"742.19","author":"Mulligan","year":"2008","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.nbd.2011.12.040_bb0560","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0565","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0570","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","article-title":"Pitx3 is required for development of substantia nigra dopaminergic neurons","volume":"100","author":"Nunes","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.040_bb0575","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/brain\/awm174","article-title":"Characteristics of orthostatic hypotension in Parkinson's disease","volume":"130","author":"Oka","year":"2007","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2011.12.040_bb0580","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/s10072-006-0546-6","article-title":"Parkinson's disease and dementia","volume":"27","author":"Padovani","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0585","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0590","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mds.20289","article-title":"No global loss of neocortical neurons in Parkinson's disease: a quantitative stereological study","volume":"20","author":"Pedersen","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0595","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model","volume":"494","author":"Perese","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0600","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0072-9752(07)83008-9","article-title":"The neuropathology of parkinsonism","volume":"83","author":"Perl","year":"2007","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0605","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1601-183X.2009.00559.x","article-title":"DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments","volume":"9","author":"Pham","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2011.12.040_bb0610","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.040_bb0615","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0620","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0625","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.040_bb0630","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-4522(00)00293-1","article-title":"Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine","volume":"101","author":"Rabinovic","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.040_bb0635","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1353-8020(01)00023-2","article-title":"Levodopa prolongs life expectancy and is non-toxic to substantia nigra","volume":"8","author":"Rajput","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0640","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0645","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.040_bb0650","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0773.1992.tb00421.x","article-title":"Acute and long term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice","volume":"70","author":"Rosland","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0655","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/mds.21076","article-title":"Association of olfactory dysfunction with incidental Lewy bodies","volume":"21","author":"Ross","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0660","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0665","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1460-9568.1996.tb01318.x","article-title":"Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia","volume":"8","author":"Salin","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0670","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.040_bb0675","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case\u2013control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.040_bb0680","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(90)90069-N","article-title":"Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys","volume":"519","author":"Schneider","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.040_bb0685","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/1055-8330(95)90014-4","article-title":"Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey","volume":"4","author":"Schneider","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.nbd.2011.12.040_bb0690","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson's disease\u2014an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0695","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0700","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ana.22018","article-title":"Environmental neurotoxin-induced progressive model of parkinsonism in rats","volume":"68","author":"Shen","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0705","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.040_bb0710","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0715","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0720","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1152\/jn.1999.81.2.858","article-title":"Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys","volume":"81","author":"Slovin","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0725","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.neurobiolaging.2008.11.010","article-title":"Selective noradrenergic vulnerability in alpha-synuclein transgenic mice","volume":"31","author":"Sotiriou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.040_bb0730","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.040_bb0735","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.parkreldis.2006.10.008","article-title":"Prevalence and treatment of non-motor symptoms in Parkinson's disease","volume":"13","author":"Sullivan","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0740","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0028-3932(99)00103-7","article-title":"Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication","volume":"38","author":"Swainson","year":"2000","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nbd.2011.12.040_bb0745","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.040_bb0750","first-page":"71","article-title":"Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG","volume":"41","author":"Takatsu","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2011.12.040_bb0755","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.nbd.2011.12.040_bb0760","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0765","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2010.10.007","article-title":"Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease","volume":"17","author":"Thompson","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0770","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0775","first-page":"H18","article-title":"Mice overexpressing human alpha synuclein under the Thy1-promotor show increased fear conditioning and altered responses in anxiety related behavior","volume":"750.25","author":"Torres","year":"2010","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.nbd.2011.12.040_bb0780","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0785","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.nbd.2011.12.040_bb0790","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.040_bb0795","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008877-200609000-00011","article-title":"Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects","volume":"17","author":"van Vliet","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0800","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/practneurol-2011-000011","article-title":"The treatment of early Parkinson's disease: levodopa rehabilitated","volume":"11","author":"Vlaar","year":"2011","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.040_bb0810","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0091-3057(80)90229-4","article-title":"Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT","volume":"13","author":"Waddington","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2011.12.040_bb0815","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1679\/aohc.52.Suppl_191","article-title":"Lewy bodies in the enteric nervous system in Parkinson's disease","volume":"52","author":"Wakabayashi","year":"1989","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0820","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.12.040_bb0825","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-011-9574-5","article-title":"Parkinson's disease risk from ambient exposure to pesticides","volume":"26","author":"Wang","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0830","first-page":"S59","article-title":"Parkinson's disease\u2014Part 3: neuropsychiatric symptoms","volume":"14","author":"Weintraub","year":"2008","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.nbd.2011.12.040_bb0835","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mds.22057","article-title":"Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations","volume":"23","author":"Whitehead","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0840","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/NMM:1:3:207","article-title":"Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour","volume":"1","author":"Wilson","year":"2002","journal-title":"Neuromolecular Med."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2011.12.040_bb0845","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1353-8020(09)70770-9","article-title":"Non-motor extranigral signs and symptoms in Parkinson's disease","volume":"15","author":"Wolters","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.040_bb0850","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","article-title":"Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice","volume":"16","author":"Yang","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.040_bb0855","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/sleep\/30.4.413","article-title":"Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism","volume":"30","author":"Yi","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.nbd.2011.12.040_bb0860","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.040_bb0865","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00702-004-0178-z","article-title":"Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions","volume":"111","author":"Zgaljardic","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.040_bb0870","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1074\/jbc.M710232200","article-title":"Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease","volume":"283","author":"Zhou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.040_bb0875","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20305","article-title":"Variable effects of chronic subcutaneous administration of rotenone on striatal histology","volume":"478","author":"Zhu","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.040_bb0880","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","article-title":"Non-motor behavioural impairments in parkin-deficient mice","volume":"26","author":"Zhu","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0885","article-title":"Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus","author":"Zhu","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.040_bb0890","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7","article-title":"Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion","volume":"427","author":"Zuch","year":"2000","journal-title":"J. Comp. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111004153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111004153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T20:02:01Z","timestamp":1561147321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111004153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":178,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0969996111004153"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.040","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}